However, mutations in other HRR genes, such as ATM, CHEK2, PALB2, NBN, MRE11, and RAD51 paralogs RAD51C and RAD51D also increase cancer risk and are already included in many screening panels for breast cancer [11,14,15]. The gene discussed is RAD51; the disease is breast cancer.